Prospects of Platelet-Rich Plasma in Regenerative Medicine


Abstract
(ISSN 2577-5820)
OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).
Prospects of Platelet-Rich Plasma in Regenerative Medicineby
![]() ![]() Abstract Platelet-rich plasma (PRP) is a promising tool in regenerative medicine because it stimulates tissue repair and regeneration. PRP contains a high concentration of platelets, growth factors, and cytokines involved in the healing process. This editorial paper aims to give an overview of PRP in regenerative medicine and its potential applications in variou [...] |
Effect of Foot Reflexology on Laboratory Tests after Kidney Transplantation Surgery: A Secondary Analysis of a Parallel Randomized Controlled Trial Studyby
![]() ![]() ![]() ![]() ![]() Abstract Foot reflexology has improved numerous physical and psychological symptoms in patients. The researchers in this study aimed to investigate the effect of foot reflexology on laboratory parameters, intake/output/weight and medication regimen after kidney transplant surgery. The research was a secondary analysis of a parallel randomized controlled trial [...] |
Successful Kidney Transplantation of Two Patients with Donors Positive for Severe Acute Respiratory Syndrome Coronavirus InfectionAbstract Despite preventative measures, including vaccination, severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection may result in severe illness, particularly in immunosuppressed transplant recipients. This has had a negative impact on organ donation and transplantation rates. However, the risk of transmission from SARS-CoV-2 positive donors [...] |
Brief Review: Pancreatic Islet Transplantation for Type 1 Diabetes in HumansAbstract Pancreatic islet transplantation (ITx) has moved from the experimental phase of development to a position of an accepted and appropriate procedure to apply in clinical medicine. The primary indication for use of ITx is for management of dangerous and recurrent hypoglycemia secondary to use of exogenous insulin for management of hyperglycemia in people [...] |
Short-Term Impact of Hematopoietic Stem Cell Transplantation in Leukemia Patients on Bone Bio Markers, Electrolytes and Blood Profileby
![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Hematopoietic stem cell transplantation (HSCT) or Bone Marrow Transplantation (BMT) has significantly improved the survival rates of patients suffering from hematological malignancies. However, the cure can only be achieved at the price of morbidity and long-term complications such as bone diseases leading to fractures and osteopenia. Several studies [...] |
A Case of Disseminated Cryptococcus Post-Kidney TransplantAbstract Cryptococcosis is a common invasive fungal infection in solid organ transplant recipients (SOTR) that can be challenging to manage. We discuss a case of disseminated cryptococcosis in a transplant recipient. A 26-year-old woman with a history of ESRD from C1q nephropathy, living-related kidney transplant in early 2012, and allograft nephrectomy in 2015 [...] |
Normal Saline vs Plasma-Lyte A Use Intra- and Post-Operatively in Adult Kidney Transplant Recipientsby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Fluid management intra- and post-operatively for kidney transplant recipients (KTR) is essential to maintain adequate perfusion to the kidney. 0.9% normal saline (NS) is commonly used, but it can cause hyperchloremic metabolic acidosis, which may result in hyperkalemia and lead to delayed graft function (DGF). Plasma-Lyte A (PA) is an alternative option [...] |
Robust Outcomes for Hispanic Lung Transplant Recipients in the United Statesby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Race, while a social construct, has a strong effect on a person’s health. There is limited data on racial disparities within lung transplantation (LTx), especially for Hispanic recipients. Therefore, the aim of this study was to identify inequalities that may involve this population. We analyzed historical data from the Organ Procurement and Transplan [...] |
A Breath of Fresh Air - Lung Transplantation Has Come of Ageby
![]() ![]() Abstract A boundless spectrum of chronic lung diseases is said to effect over 500 million persons globally. Lung transplantation is a well-established therapeutic option for patients suffering from end-stage lung diseases, however waitlist mortality and primary graft failure remain major determinants as post-transplantation 5-year survival is just above 50 perce [...] |
Mobilization of Autologous Peripheral Blood Stem Cells (PBSC) in CD20+ Lymphoma Patients Using RICE, Granulocyte-Colony Stimulating Factor (G-CSF) and PlerixaforAbstract RICE is salvage therapy for treating CD20+non-Hodgkin lymphoma (NHL). It is combined with G-CSF to collect autologous peripheral blood stem cells (aPBSC). Little data exists, though, on the combination of G-CSF and Plerixafor after RICE in mobilizing adequate number of CD34 cells and the product’s immune content. We report on the results of twent [...] |
Monitoring Survival Following Lung Transplantation with Inclusion of Unaccounted Risksby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Lung transplant (LTx) survival and quality of life have been steadily improving, partially from changes in candidate selection for transplantation. There are well-known high-risk factors that lead to poor LTx outcomes, which may be referred to as ‘accounted’ risks. However, there are also other ‘unaccounted’ risks that are not included in the [...] |
Impact of Sex and Age at Lung Transplantation on Long-Term Survival of Patients with Cystic FibrosisAbstract Careful selection of lung transplant (LT) recipients with cystic fibrosis (CF) may improve outcomes; therefore, we studied the impact of sex and age at the time of LT on long-term survival of patients with CF. LT recipients with CF who received post-LT care at our center between July 1, 2007 and April 30, 2021 were included. The primary outcome was [...] |
Non-Renal Factors Associated with Simultaneous Liver-Kidney Transplant in Patients with End-Stage Liver Disease and Stage 3-5 Chronic Kidney Disease Not Requiring DialysisAbstract We aimed to identify the non-renal risk factors for simultaneous liver-kidney transplantation (SLKT) vs. liver transplantation alone (LTA) in end-stage liver disease (ESLD) patients with estimated glomerular filtration rate (eGFR) 60 years (OR = 0.25, CI = 0.19-0.32), female recipient sex (OR = 0.48, CI = 0.43-0.54), hepatocellular carcinoma (OR = [...] |
Cytomegalovirus and Kidney Transplantation: An UpdateAbstract Cytomegalovirus (CMV) infection is the most common infection affecting kidney transplant recipients [1]. CMV may be present as asymptomatic viremia or with symptoms ranging from mild to significant tissue-invasive disease [1-3]. Optimal kidney graft function and survival requires that transplant care teams carefully assess individual patient risk of [...] |
Lung Transplantation from A Donor with Previous SARS-CoV-2 Infection: 1-Year Outcomesby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Few reports have described successful lung transplantation from a donor with a history of SARS-CoV-2 infection, and outcomes beyond 3 to 6 months remain unknown. After weighing the urgency and life-saving benefits of lung transplantation against the risk of viral transmission, we successfully performed a bilateral lung transplant from a donor with confi [...] |
Acknowledgement to Reviewers of OBM Transplantation in 2022Abstract The editors of OBM Transplantation would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2022. We greatly appreciate the contribution of expert reviewers, which is crucial to the journal’s editorial process. We aim to recognize reviewer contributions through several mechanisms, of which the annual public [...] |
Islet Transplantation: How Much Have We Advanced and How to Keep Moving Forward?Abstract EditorialIslet Transplantation: How Much Have We Advanced and How to Keep Moving Forward?Braulio A. Marfil-Garza 1, Tatsuya Kin 1, 2, *1. Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada; E-Mails: marfilga@ualberta.ca; tkin@ualberta.ca2. Alberta Islet Distribution Program, Clinical Islet Laboratory, Edmonton, Alberta [...] |
Shifting Pancreas Transplantation Rates and Demographics are the Culmination of Many Strategic Policy Changesby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract The 2014 Pancreas Allocation System established national qualifying criteria for simultaneous kidney pancreas (SPK) transplantation. The 2019 UNOS Pancreas Transplantation Committee Policy 11.3.B modified these guidelines to expand transplantation. Subsequent effects on recipient demographics have not been studied. We analyzed 81 SPK transplantations [...] |
"Let's Live Life - Let's Give Life”: Donor Program Improvement as the Key to Transplantation Success in 21st Century - A Croatian ExperienceAbstract Transplantation is a widely accepted and successful life-saving treatment for hundreds of thousands of patients. However, transplant medicine still faces a number of obstacles. One of the most significant is the large disparity between the number of donors and recipients and the growing need for re-transplantation. In the last two decades, the improveme [...] |
Hepatitis B Reactivation in HBsAg Negative Renal Transplant Patients with Evidence of Previous HBV Infection: A Not Neglectable Occurrenceby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Hepatitis B virus (HBV) infection is frequent among patients with chronic kidney disease (CKD). HBV reactivation after kidney transplant (KT) is more common in patients with HBsAg+; however, it can also occur in previously infected individuals, particularly those with HBsAg negative and total antiHBc positive (HBsAg-/antiHBcT+). However, reactivation [...] |
The P2X7 Receptor Antagonist AZ10606120 Does Not Alter Graft-Versus-Host Disease Development and Increases Serum Human Interferon-γ in a Humanized Mouse ModelAbstract Allogeneic hematopoietic stem cell transplantation is a curative therapy for hematological malignancies, but its efficacy is limited by graft-versus-host disease (GVHD). This life-threatening disorder develops when donor (graft) immune cells cause inflammatory damage to recipient (host) tissues. The immune cell receptor channel P2X7 and its ligand adeno [...] |
Open Access Short Communication Promising Tactics with Certain Probiotics for the Treatment of Nephropathy in Hematopoietic Stem Cell TransplantationAbstract Hematopoietic stem cell transplantation (HSCT) is a standard form of cellular therapy for patients suffering from malignant hematological diseases. However, graft-versus-host disease (GVHD) is a very serious complication and a major cause of morbidity and mortality after allogeneic HSCT. Calcineurin inhibitors, such as cyclosporine, are widely used [...] |
Bilateral Corneal Perforation in a Patient with Chronic Ocular Graft-Versus-Host Disease: A Case Report and Literature Reviewby
![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Graft-versus-host disease (GVHD) is a serious complication that may occur in patients receiving allogeneic hematopoietic stem cell transplant (HSCT). GVHD occurs because of the immunological reaction between the donor’s T cells and the recipient’s antigens; GVHD may develop in different tissues, including the eye. Corneal perforation is an uncommon [...] |
The Role of Cytochrome P450 2J2 in Cancer: Cell Protector, Therapeutic Target, or Prognostic Marker?Abstract Cytochrome P450 2J2 (CYP2J2) is one of the recently discovered enzymes that is involved in the metabolism of several drugs. It is mainly an extrahepatic enzyme which can, to some extent, explain some the drugs’ side effects such as cyclophosphamide (Cy). Cyclophosphamide is an alkylating agent that is commonly used in conditioning prior to stem cell [...] |
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Maurizio Salvadori from Careggi University Hospital, Italy, to join the Editorial Board of OBM Transplantation. Prof. Salvadori is a Professor, Professor, Department of Renal Transplantation, Careggi University Hospital, viale Pieraccini 18, 50139 Florence, Italy. Prof. Salvadori has extensive experience in kidney transplantation, transplantation, clinical nephrology, chronic renal failure, immunology, infectious diseases, and antibody-mediated rejection. We are grateful to Prof. Salvadori for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Tatsuya Kin from University of Alberta, Canada, to join the Editorial Board of OBM Transplantation. Dr. Kin is the Director, Clinical Islet Laboratory, Department of Surgery, University of Alberta, 112 Street & 87 Avenue, Edmonton, AB T6G 2E1, Canada. Dr. Kin has extensive experience in islet isolation, islet transplantation, organ preservation, organ donation, transplantation, and diabetes. We are grateful to Dr. Kin for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Luca Brazzi from University of Turin, Italy, to join the Editorial Board of OBM Transplantation. Prof. Brazzi is a Professor, Chief, Director, Department of Surgical Science, University of Turin, University Hospital Città della Salute e della Scienza, Corso Dogliotti 14, 10126 Turin, Italy. Prof. Brazzi has extensive experience in anaesthesiology, transplant anaesthesiology, anaesthetics, and preservation of donor organs. We are grateful to Prof. Brazzi for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Nidhi Sharma from Ohio State University, USA, to join the Editorial Board of OBM Transplantation. Dr. Sharma is from Division of Hematology, Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH, USA. Dr. Sharma’s research interest is in the field of stem cell transplantation (autologous and allogenic), and graft vs host disease (GVHD). We are grateful to Dr. Sharma for the participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Marina Moguilevitch from Montefiore Medical Center, Albert Einstein College of Medicine, USA, to join the Editorial Board of OBM Transplantation. Prof. Moguilevitch is an Associate Professor of Clinical Anesthesiology, Director of Transplant Anesthesia Service, Divsion of Transplant Anesthesiolgy, Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA. She has extensive experience in anesthesiology, transplant anesthesiology, and liver transplantation. We are grateful to Prof. Moguilevitch for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Malcolm Voyce from Macquarie Law School, Macquarie University, Australia, to join the Editorial Board of OBM Transplantation. Prof. Voyce is a Professor of Law, Macquarie Law School, Macquarie University, NSW 2109 Australia. He has extensive experience in property law and succession concerning the privatisation of public property, geographical indications, intellectual property rights, social welfare, family farm inheritance and organ transplants, law and religion, and Buddhism and Islam. We are grateful to Prof. Voyce for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Maricar Malinis from Yale School of Medicine, USA, to join the Editorial Board of OBM Transplantation. Dr. Malinis is an Associate Professor of Medicine and Surgery (Transplant), Medical Director, Transplant Infectious Diseases, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA. She has extensive experience in aging, CMV, fungal infections, immunocompromised host and transplant infectious diseases. We are grateful to Dr. Malinis for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Paolo Muiesan from Queen Elizabeth & Birmingham Children's Hospitals, USA, to join the Editorial Board of OBM Transplantation. Professor Muiesan is the Professor of HPB Surgery & Liver Transplantation, Liver Unit, Queen Elizabeth & Birmingham Children's Hospitals, Mindelsonway, Birmingham B15 2TH, United Kingdom. He has extensive experience in adult and paediatric liver transplantation, hepatobiliary surgery, liver tumors, general surgery, vascular surgery, laparoscopic liver surgery, liver resections for cholangiocarcinoma, parenchymal sparing central resections, ALPPS and ex-vivo resections. We are grateful to Prof. Muiesan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Mohammed Moghadasian from University of Manitoba, Canada, to join the Editorial Board of OBM Transplantation. Professor Moghadasian is the Professor of Nutrition, Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. He has extensive experience in diet, lipoprotein metabolism, coronary artery disease, diet-drug interaction, and diets and transplantation. We are grateful to Prof. Moghadasian for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Esma S. Yolcu to join the Editorial Board of OBM Transplantation. Dr. Yolcu is an Associate Professor at Department of Microbiology and Immunology, Institute for Cellular Therapeutics, University of Louisville School of Medicine, Louisville, USA. Her main research interests are immunotherapy, ProtEx™ technology, gene therapy, immunomodulation, tolerance, host-versus-graft (HVG) and graft-versus-host (GVH). We are grateful to Dr. Yolcu for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We sincerely welcome Professor Haval Shirwan from University of Louisville, USA, to lead the journal OBM Transplantation as the Editor-in-Chief. Professor Shirwan is an internationally renowned immunologist recognized for his pioneering approach to generate novel immunological ligands and their transient and positional display on biologic and nonbiologic surfaces for localized immunomodulation with applications to transplantation, autoimmunity, and cancer immunoprevention and immunotherapy. We appreciate Professor Haval Shirwan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Mureo Kasahara from National Center for Child Health and Development, Tokyo, Japan, to join the Editorial Board of OBM Transplantation. Prof. Kasahara is the Director, Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan. He has extensive clinical experience in the kidney transplantation, liver transplantation, liver surgery, pediatric organ transplantation, liver diseases and immunology, transplant immunology, transplant medicine and transplant surgery. We are grateful to Prof. Kasahara for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Associate Professor Chirag S. Desai to join the Editorial Board of OBM Transplantation. Dr. Desai is an Associate Professor at Department of Surgery, University of North Carolina, Chapel Hill, NC, USA. His main research interests are liver transplantation, intestinal and multivisceral transplantation, liver and pancreatobiliary disorders, chronic pancreatitis and autologous islet cell transplantation. We are grateful to Dr. Desai for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Sherif Beniameen Mossad to join the Editorial Board of OBM Transplantation. Dr. Mossad is a staff physician in the Department of Infectious Disease, Respiratory Institute, and Transplantation Center, Cleveland Clinic, Ohio, USA. His main research interests are transplant infectious disease, influenza and common cold. We are grateful to Dr. Mossad for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor René Adam to join the Editorial Board of OBM Transplantation. Dr. Adam is a Professor and Head Department of Hepatobiliary Surgery, Cancer and Transplantation, Centre Hepato-Biliaire, Hopital Paul-Brousse, 94804 Villejuif, France. His main research interests are surgery of the liver, biliary tract and pancreas, hepatic transplantation, liver diseases, hepatocellular carcinoma, hepatobiliary surgery, and liver transplantation. We are grateful to Dr. Adam for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Yasuhiko Sugawara to join the Editorial Board of OBM Transplantation. Dr. Sugawara is a Professor at Department of Surgery, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Japan. His main research interests are hepatobiliary surgery and liver transplantation. We are grateful to Dr. Sugawara for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Taizo Hibi to join the Editorial Board of OBM Transplantation. Dr. Hibi is a Professor and Chairman at the Department of Transplantation and Pediatric Surgery, Kumamoto University Graduate School of Medical Sciences, Japan. His main research interests are surgical oncology, hepatobiliary and pancreatic surgery, living donor liver transplantation, intestinal/multivisceral transplantation, and transplant/tumor immunology. We are grateful to Dr. Hibi for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Kåre I. Birkeland to join the Editorial Board of OBM Transplantation. Dr. Birkeland is a Professor at the Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway. His main research interests are diabetes, clinical and mechanistic studies; insulin resistance and metabolic syndrome; laboratory endocrinology; and islet and pancreas transplantation. We are grateful to Dr. Birkeland for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Waldo Concepcion from Stanford University, USA, to join the Editorial Board of OBM Transplantation. Professor Concepcion is the Chief of Clinical Transplantation, Stanford University Medical Center and the Chief of Pediatric Kidney Transplantation, Lucille Packard Children's Hospital. He has extensive clinical and research experience in liver and kidney transplantation and has published over 104 peer reviewed articles. We are grateful to Professor Concepcion for his participation and support.
OBM Transplantation Welcomes the Founding Editor-in-Chief — Professor Pål Dag Line
We welcome Professor Pål Dag Line, from Oslo University, Norway, to lead the journal OBM Transplantation as the founding Editor-in-Chief. Professor Line is also the Head of Department of Organ Transplantation at Oslo University Hospital. He is an internationally recognized expert specializing in transplant surgery, vascular surgery, and HPB surgery, etc. He has published over 118 peer reviewed articles in international professional journals. We are very grateful to Professor Line for his participation and great support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Milagros D. Samaniego-Picota from University of Michigan, USA, to join the Editorial Board of OBM Transplantation. Professor Samaniego-Picota's clinical and research interests focus on experimental and clinical antibody-mediated rejection, desensitization protocols, and the care of highly sensitized patients. We are grateful to Professor Samaniego-Picota for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Haley Hoy from the University of Alabama in Huntsville, USA, to join the Editorial Board of OBM Transplantation. Dr. Hoy has extensive clinical and research experience in Pulmonary, Nursing and Transplantation, Quality of life, Web-based Mobile Technology, etc. We are grateful to Dr. Hoy for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Kamyar Afshar from UCSD Pulmonary, Critical Care and Sleep Medicine, USA, to join the Editorial Board of OBM Transplantation. Dr. Afshar is a board-certified pulmonologist who specializes in complex lung diseases and lung transplantation. He is also a member of numerous professional organizations, including the International Society of Heart and Lung Transplant, the American Thoracic Society, the American College of Chest Physicians, and the Society of Critical Care Medicine, etc. We are grateful to Dr. Afshar for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Muhammad Mujtaba from the University of Texas Medical Branch Galveston, USA, to join the Editorial Board of OBM Transplantation. Dr. Mujtaba has extensive clinical and research experience in kidney and pancreas transplantation including high risk transplant, immunomodulation/desensitization protocols, early steroid withdrawal, antibody mediated rejection, post-transplant antibody monitoring, and BK virus management post-transplant, etc. We are grateful to Dr. Mujtaba for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Wasim A. Dar from the University of Texas at Houston, USA, to join the Editorial Board of OBM Transplantation. Dr. Dar specializes in abdominal solid organ transplantation, laparoscopic donor nephrectomy for living donor kidney transplantation, and hepatobiliary surgery for benign and malignant disease. His research interests include basic-science and clinical research in the study of organ transplant immunology and clinical outcomes related to organ transplant. We are grateful to Dr. Dar for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Jeffrey B. Halldorson from the University of California at San Diego, USA, to join the Editorial Board of OBM Transplantation. Dr. Halldorson is an Associate Professor of Surgery specializing in all aspects of Liver, Kidney and Pancreas transplantation as well as Liver and Hepatobiliary surgery and general surgery as applied to the transplant patient. Dr. Halldorson has authored numerous manuscripts in peer reviewed journals regarding his research in improving outcomes of donor organs and recipients by optimizing the matching process. We are grateful to Dr. Halldorson for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Malek G. Massad from University of Illinois, USA, to join the Editorial Board of OBM Transplantation. Professor Massad is the Chief of the University of Illinois Hospital Cardiothoracic Surgery team. His team provides an innovative approach to cardiac and thoracic diseases. We are grateful to Professor Massad for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Simon C. Robson to join the Editorial Board of OBM Transplantation. Professor Robson is a physician scientist in the Liver Center and Transplant Institute at the Beth Israel Deaconess Medical Center, Harvard University in Boston, where he served as Chief of Gastroenterology and Hepatology, as well as Director of Liver Research. We are grateful to Professor Robson for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Raman Venkataramanan from University of Pittsburgh, USA, to join the Editorial Board of OBM Transplantation. Professor Venkataramanan is the Director of the Clinical Pharmacokinetics Laboratory at University of Pittsburgh. His research focuses on the functional capacity of transplanted organs and optimization of immunosuppressive drug therapy in organ transplant patients. Professor Venkataramanan has presented more than 175 lectures/seminars at national/international meetings and published over 350 research articles. We are grateful to Professor Venkataramanan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Gian Luigi Adani from the University Hospital of Udine, Italy, to join the Editorial Board of OBM Transplantation. Dr. Adani is an expert specializes in liver transplantation, hepatocellular carcinoma, and liver surgery, etc. We are grateful to Dr. Adani for his participation and support.
OBM Transplantation welcomes the following types of articles: original research, review, communication, opinion, case report, comment, conference report, technical note, book review, etc. There is no restriction on the length of the papers, color figures, supplementary file types. More details please see Instructions for Authors.
Research Article
by Scott A. Campbell et al.
OBM Transplantation 2023
Published: 26 June 2019
Original Research
by Gopalakrishnan Loganathan et al.
OBM Transplantation 2023
Published: 24 May 2019
Research Article
by Darren Stewart et al.
OBM Transplantation 2023
Published: 22 January 2019
TOP